Horsham, United Kingdom

Matthew Spendiff

USPTO Granted Patents = 3 


Average Co-Inventor Count = 8.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Matthew Spendiff: Innovator in Pharmaceutical Chemistry

Introduction

Matthew Spendiff is a notable inventor based in Horsham, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific biological pathways. With a total of 3 patents to his name, Spendiff's work is paving the way for advancements in medical treatments.

Latest Patents

Matthew Spendiff's latest patents include innovative compounds designed to inhibit the activity of phosphatidylinositol 3-kinase gamma isoform. The first patent, titled "Amino pyridine derivatives as phosphatidylinositol 3-kinase inhibitors," presents compounds that are useful for treating diseases mediated by the activation of this isoform. The second patent, "Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors," similarly focuses on compounds that inhibit the same activity, showcasing his dedication to addressing critical health issues.

Career Highlights

Spendiff is currently associated with Novartis AG, a leading global healthcare company. His role at Novartis allows him to collaborate with other experts in the field and contribute to groundbreaking research and development efforts. His work is characterized by a commitment to innovation and a focus on improving patient outcomes through targeted therapies.

Collaborations

Matthew Spendiff has worked alongside talented colleagues, including Benjamin Richard Bellenie and Ian Bruce. These collaborations have fostered an environment of creativity and shared knowledge, further enhancing the impact of their collective research.

Conclusion

In summary, Matthew Spendiff is a distinguished inventor whose work in pharmaceutical chemistry is making a significant impact on medical science. His innovative patents and collaborations reflect his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…